Hims & Hers Health Inc. buy Barclays PLC
Start price
08.12.25
/
50%
€33.75
Target price
08.12.26
-
Performance (%)
-19.17%
Price
20.08.26
€27.28
Summary
This prediction is currently active. The price of Hims & Hers Health Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.17%. This prediction currently runs until 08.12.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | 9.295% | 9.295% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by Barclays_PLC for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Stopped prediction by Barclays_PLC for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€27.88
17.06.26
17.06.26
-
17.06.27
17.06.27
-2.15%
20.08.26
20.08.26
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€22.94
11.03.26
11.03.26
€24.96
11.03.27
11.03.27
18.92%
20.08.26
20.08.26